Table 1.
Characteristics | Discovery (n = 269) | Validation (n = 269) | ||
---|---|---|---|---|
Benign (n = 197) | Malignant (n = 72) | Benign (n = 196) | Malignant (n = 73) | |
Age (years): | ||||
Mean | 50.41 | 55.58 | 50.29 | 54.63 |
Median | 50.00 | 55.00 | 50.00 | 56.00 |
Range | 30–70 | 32–70 | 25–82 | 40–72 |
Race: | ||||
Chinese | 160 | 64 | 152 | 65 |
non-Chinese | 37 | 8 | 44 | 8 |
Tumor stage: | ||||
Stage 0 | - | 26 | - | 27 |
Stage 1 | - | 26 | - | 26 |
Stage 2 | - | 18 | - | 16 |
Stage 3 | - | 2 | - | 4 |
Tumor size: | ||||
≤10 mm | - | 20 | - | 20 |
11 to 20 mm | - | 30 | - | 25 |
>20 mm | - | 24 | - | 28 |
Unknown | - | 3 | - | 2 |
Tumor grade: | ||||
Grade 1 | - | 16 | - | 18 |
Grade 2 | - | 29 | - | 32 |
Grade 3 | - | 23 | - | 22 |
Unknown | - | 4 | - | 1 |
Lymph node status: | ||||
Positive | - | 51 | - | 54 |
Negative | - | 17 | - | 14 |
Unknown | - | 4 | - | 5 |